Immunocore Holdings Income Statement (2021-2025) | IMCR

Income Statement Mar2021 Sep2021 Dec2021 Jun2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 11.41M7.98M8.90M38.92M67.84M54.66M59.76M64.85M70.16M70.50M75.40M80.25M84.05M93.88M97.96M103.69M
Cost of Revenue 0.04M0.70M0.22M0.35M0.28M0.20M0.25M1.71M0.45M0.33M0.83M1.04M0.51M
Gross Profit 38.88M67.13M54.44M59.41M64.57M69.96M70.26M73.69M79.80M83.72M93.05M96.92M103.18M
Operating items
Research & Development -27.43M-22.63M-27.10M-24.51M170.99M36.57M38.16M43.25M45.56M57.46M51.07M52.77M60.85M56.47M69.01M70.57M
Selling, General & Administrative -27.84M-27.00M-32.89M-22.88M179.38M32.57M35.01M35.47M41.45M39.29M38.64M35.53M42.32M40.20M42.79M39.78M
Other Operating Expenses -0.11M-0.04M0.02M
Operating Expenses -55.27M-49.63M-59.99M-47.38M350.36M69.14M73.17M78.72M87.01M96.75M89.71M88.30M103.17M96.67M111.80M110.35M
Operating Income -43.98M-41.69M-51.07M-8.50M-32.47M-14.70M-13.76M-14.14M-17.05M-26.49M-16.02M-8.50M-19.45M-3.62M-14.88M-7.17M
EBIT -43.98M-41.69M-51.07M-8.50M-32.47M-14.70M-13.76M-14.14M-17.05M-26.49M-16.02M-8.50M-19.45M-3.62M-14.88M-7.17M
Non-operating items
Interest & Investment Income 0.03M0.01M0.01M0.14M2.95M3.13M4.28M5.14M5.44M8.25M6.24M5.96M5.17M4.18M4.27M4.12M
Other Non Operating Income -6.01M-5.88M11.25M-12.47M-2.41M4.43M8.96M0.99M5.47M4.69M5.06M
Non Operating Income -1.76M-1.81M-1.55M2.54M-0.33M-0.19M-0.19M-0.19M-0.19M4.43M8.96M0.99M5.47M4.69M5.06M
Net income details
EBT -46.52M-43.45M-52.88M-10.06M-17.42M-19.16M-16.82M0.73M-25.64M-24.08M-10.13M6.09M-24.82M6.08M-9.69M0.30M
Tax Provisions -0.29M0.30M0.19M-0.17M-5.91M0.40M1.50M-2.64M-1.05M1.10M0.61M0.50M
Profit After Tax -40.06M-40.59M-53.17M-7.44M-34.71M-19.45M-17.01M0.91M-19.73M-24.44M-11.62M8.74M-23.77M5.02M-10.30M-0.18M
Income from Continuing Operations -46.52M-43.45M-52.60M-10.06M-17.42M-19.46M-17.01M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M
Consolidated Net Income -46.52M-43.45M-52.60M-10.06M-17.42M-19.46M-17.01M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M
Income towards Parent Company -46.52M-43.45M-52.60M-10.06M-17.42M-19.46M-17.01M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M
Net Income towards Common Stockholders -46.52M-43.45M-52.60M-10.06M-17.42M-19.46M-17.01M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M
Additional items
EPS (Basic) -0.40-0.350.02-0.40-0.49-0.230.17-0.480.10-0.200.00
EPS (Weighted Average and Diluted) -0.40-0.350.02-0.40-0.49-0.230.17-0.480.10-0.200.00
Shares Outstanding (Weighted Average) 50.0048.89M49.88M50.01M50.02M49.99M50.09M50.29M50.40M
Shares Outstanding (Diluted Average) 48.89M49.88M50.01M52.81M49.99M51.95M50.29M50.40M
EBITDA -43.98M-41.69M-51.07M-8.50M-32.47M-12.02M-10.24M-14.04M-0.57M-23.54M-10.67M11.98M-26.36M5.70M-3.82M-3.57M
Interest Expenses -2.56M-1.77M-1.82M-1.70M10.44M1.25M1.27M1.32M1.31M3.24M4.28M4.29M7.04M3.02M3.04M3.04M
Tax Rate 0.55%-1.57%-1.14%-23.94%23.05%-1.66%-14.81%-43.38%4.23%18.08%-6.25%164.47%